InvestorsHub Logo
Followers 3
Posts 251
Boards Moderated 0
Alias Born 04/23/2013

Re: eZ3 post# 40153

Tuesday, 10/02/2018 2:42:39 PM

Tuesday, October 02, 2018 2:42:39 PM

Post# of 64409
Every choice has its inherent rewards and consequences, eZ3.

I would like your thoughts on this concept...
Putting the CEO's character or lack there of aside, I also think that NPHC is competing with the MJ sector for this whole notion of "there's an opioid crisis and we need alternatives"...... basically CBD vs. Snake venom.
Not being sarcastic or anything, I'm in for a speculative gamble at these prices. Curious to know your thoughts...

Nyloxin failed to meet the government standards for an opioid replacement: Double-blind, placebo-controlled, published and peer-reviewed.

I posted my DD over a year ago plus many warnings since:

Source: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134877446

Source: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136184130

Presumably, some heeded my warnings moved on. However, those who ignored me remain in Rik and cronies’ favorite group.

As bad as my prognostication was then, it’s far worse now, assuming; the SEC staff is under tremendous pressure to justify prioritizing its investigation and prosecutorial budget. Therefore, I believe, Friday’s revelation was just the beginning.

Thinking